HopeStage
Back to all studies
RecruitingNCT05942313

Pregnancy outcomes among people with opioid use disorder: a follow-up study

About this titleRead the official source — NCT05942313
Observational studyAges 18+United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
PittsburghSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: August 28, 2023
Recruitment status
Recruiting
Enrollment listed in the registry
100
Sponsor
Ilana Hull
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Drug
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT05942313
Official title
Show the full official title

Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy

Recruitment & locations

Currently recruiting

Pittsburgh

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Ilana Hull.

Does this study involve medication?

Yes. The study involves medication, including Buprenorphine/ Methadone exposure.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies